Evoke Pharma (EVOK) Other Working Capital Changes (2020 - 2025)
Historic Other Working Capital Changes for Evoke Pharma (EVOK) over the last 5 years, with Q3 2025 value amounting to -$154688.0.
- Evoke Pharma's Other Working Capital Changes rose 3200.11% to -$154688.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6810.0, marking a year-over-year increase of 8654.02%. This contributed to the annual value of -$29803.0 for FY2024, which is 7702.23% up from last year.
- Evoke Pharma's Other Working Capital Changes amounted to -$154688.0 in Q3 2025, which was up 3200.11% from -$238459.0 recorded in Q2 2025.
- Over the past 5 years, Evoke Pharma's Other Working Capital Changes peaked at $719644.0 during Q4 2024, and registered a low of -$333307.0 during Q1 2025.
- For the 4-year period, Evoke Pharma's Other Working Capital Changes averaged around -$75879.8, with its median value being -$232972.5 (2024).
- As far as peak fluctuations go, Evoke Pharma's Other Working Capital Changes surged by 294120.83% in 2023, and later plummeted by 5010.79% in 2025.
- Evoke Pharma's Other Working Capital Changes (Quarter) stood at -$24597.0 in 2022, then soared by 2941.21% to $698852.0 in 2023, then rose by 2.98% to $719644.0 in 2024, then crashed by 121.5% to -$154688.0 in 2025.
- Its Other Working Capital Changes stands at -$154688.0 for Q3 2025, versus -$238459.0 for Q2 2025 and -$333307.0 for Q1 2025.